ADA Scientific Sessions 2026 Abstract

Early Real-World Liver Biomarker Changes among Resmetirom-Treated MASH Patients, with and without Concomitant GLP-1 Use: A Descriptive Cohort Study

Study in peopleInterventions

The paper